Company Profile

Hermes Life Sciences Ltd
Profile last edited on: 10/15/2020      CAGE: 875Y7      UEI: JPVWZEYKLXN3

Business Identifier: Poin of care more accurate and accessible blood testing
Year Founded
2018
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

100 Morrissey Boulevard
Boston, MA 02125
   (847) 502-4007
   N/A
   www.hermeslifesciences.com
Location: Single
Congr. District: 08
County: Suffolk

Public Profile

Offering portable blood plamsa separation in less than two minutes, Hermes Life Sciences personnel have developed the HERMES system described as the first assay agnostic blood-plasma separation platfrom from CLIA-wiaved testing faciities. HERMES - The High Efficiency Rapid Magnetic Erythrocyte Separator (HERMES) is a novel method to perform low cost blood-plasma separation at the point-of-need. With the help of functionalized magnetic microbeads that capture red blood cells, HERMES separates plasma from blood within two minutes. It does not require the use of a centrifuge or any specialized lab equipment and is particularly suited for advancing the usability of lateral flow diagnostics, which have a high potential for application at the point-of-need.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NSF $1,195,489
Project Title: Pre-diagnostic Blood-Plasma Separation at the Point-of-Care

Key People / Management

  Sasank Vemulapati -- Founder and CEO

Company News

There are no news available.